Literature DB >> 28097490

Glucose Uptake and Triacylglycerol Synthesis Are Increased in Barth Syndrome Lymphoblasts.

Edgard M Mejia1, James C Zinko1, Kristin D Hauff1,2, Fred Y Xu1, Amir Ravandi3, Grant M Hatch4,5.   

Abstract

Barth syndrome (BTHS) is an X-linked genetic disease resulting in loss of cardiolipin (Ptd2Gro). Patients may be predisposed to hypoglycemia and exhibit increases in whole-body glucose disposal rates and a higher fat mass percentage. We examined the reasons for this in BTHS lymphoblasts. BTHS lymphoblasts exhibited a 60% increase (p < 0.004) in 2-[1,2-3H(N)]deoxy-D-glucose uptake, a 40% increase (p < 0.01) in glucose transporter-3 protein expression, an increase in phosphorylated-adenosine monophosphate kinase (AMPK) and a 58% increase (p < 0.001) in the phosphorylated-AMPK/AMPK ratio compared to controls. In addition, BTHS lymphoblasts exhibited a 90% (p < 0.001) increase in D-[U-14C]glucose incorporated into 1,2,3-triacyl-sn-glycerol (TAG) and a 29% increase (p < 0.025) in 1,2-diacyl-sn-glycerol acyltransferase-2 activity compared to controls. Thus, BTHS lymphoblasts exhibit increased glucose transport and increased glucose utilization for TAG synthesis. These results may, in part, explain why BTHS patients exhibit an increase in whole-body glucose disposal rates, may be predisposed to hypoglycemia and exhibit a higher fat mass percentage.

Entities:  

Keywords:  Barth syndrome; Cardiolipin; Glucose transport; Metabolism; Triacylglycerol synthesis

Mesh:

Substances:

Year:  2017        PMID: 28097490     DOI: 10.1007/s11745-017-4232-7

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  18 in total

1.  Inhibition of mitochondrial respiration by nitric oxide rapidly stimulates cytoprotective GLUT3-mediated glucose uptake through 5'-AMP-activated protein kinase.

Authors:  Pilar Cidad; Angeles Almeida; Juan P Bolaños
Journal:  Biochem J       Date:  2004-12-15       Impact factor: 3.857

2.  Differential regulation of the GLUT1 and GLUT3 glucose transporters by growth factors and pro-inflammatory cytokines in equine articular chondrocytes.

Authors:  Toby Phillips; Ivan Ferraz; Susan Bell; Peter D Clegg; Stuart D Carter; Ali Mobasheri
Journal:  Vet J       Date:  2005-03       Impact factor: 2.688

Review 3.  Mitochondrial phospholipids: role in mitochondrial function.

Authors:  Edgard M Mejia; Grant M Hatch
Journal:  J Bioenerg Biomembr       Date:  2016-04       Impact factor: 2.945

4.  Reduction in cardiolipin decreases mitochondrial spare respiratory capacity and increases glucose transport into and across human brain cerebral microvascular endothelial cells.

Authors:  Hieu M Nguyen; Edgard M Mejia; Wenguang Chang; Ying Wang; Emily Watson; Ngoc On; Donald W Miller; Grant M Hatch
Journal:  J Neurochem       Date:  2016-09-04       Impact factor: 5.372

5.  Dysfunctional cardiac mitochondrial bioenergetic, lipidomic, and signaling in a murine model of Barth syndrome.

Authors:  Michael A Kiebish; Kui Yang; Xinping Liu; David J Mancuso; Shaoping Guan; Zhongdan Zhao; Harold F Sims; Rebekah Cerqua; W Todd Cade; Xianlin Han; Richard W Gross
Journal:  J Lipid Res       Date:  2013-02-14       Impact factor: 5.922

Review 6.  Biosynthesis, remodeling and turnover of mitochondrial cardiolipin.

Authors:  Michael Schlame; Miriam L Greenberg
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2016-08-21       Impact factor: 4.698

7.  Regulation of cardiolipin biosynthesis in H9c2 cardiac myoblasts by cytidine 5'-triphosphate.

Authors:  G M Hatch; G McClarty
Journal:  J Biol Chem       Date:  1996-10-18       Impact factor: 5.157

8.  Berberine treatment attenuates the palmitate-mediated inhibition of glucose uptake and consumption through increased 1,2,3-triacyl-sn-glycerol synthesis and accumulation in H9c2 cardiomyocytes.

Authors:  Wenguang Chang; Li Chen; Grant M Hatch
Journal:  Biochim Biophys Acta       Date:  2016-01-07

9.  Cellular localization and characterization of Glut 3 glucose transporter isoform in human brain.

Authors:  G J Mantych; D E James; H D Chung; S U Devaskar
Journal:  Endocrinology       Date:  1992-09       Impact factor: 4.736

Review 10.  Barth syndrome.

Authors:  Sarah L N Clarke; Ann Bowron; Iris L Gonzalez; Sarah J Groves; Ruth Newbury-Ecob; Nicol Clayton; Robin P Martin; Beverly Tsai-Goodman; Vanessa Garratt; Michael Ashworth; Valerie M Bowen; Katherine R McCurdy; Michaela K Damin; Carolyn T Spencer; Matthew J Toth; Richard I Kelley; Colin G Steward
Journal:  Orphanet J Rare Dis       Date:  2013-02-12       Impact factor: 4.123

View more
  5 in total

Review 1.  Mitochondrial dysfunctions in barth syndrome.

Authors:  Sagnika Ghosh; Donna M Iadarola; Writoban Basu Ball; Vishal M Gohil
Journal:  IUBMB Life       Date:  2019-02-11       Impact factor: 3.885

Review 2.  Barth syndrome: cardiolipin, cellular pathophysiology, management, and novel therapeutic targets.

Authors:  Hana M Zegallai; Grant M Hatch
Journal:  Mol Cell Biochem       Date:  2021-01-07       Impact factor: 3.396

3.  SS-31 Peptide Reverses the Mitochondrial Fragmentation Present in Fibroblasts From Patients With DCMA, a Mitochondrial Cardiomyopathy.

Authors:  Pranav Machiraju; Xuemei Wang; Rasha Sabouny; Joshua Huang; Tian Zhao; Fatima Iqbal; Melissa King; Dimple Prasher; Arijit Lodha; Nerea Jimenez-Tellez; Amir Ravandi; Bob Argiropoulos; David Sinasac; Aneal Khan; Timothy E Shutt; Steven C Greenway
Journal:  Front Cardiovasc Med       Date:  2019-11-15

4.  Phosphokinome Analysis of Barth Syndrome Lymphoblasts Identify Novel Targets in the Pathophysiology of the Disease.

Authors:  Prasoon Agarwal; Laura K Cole; Abin Chandrakumar; Kristin D Hauff; Amir Ravandi; Vernon W Dolinsky; Grant M Hatch
Journal:  Int J Mol Sci       Date:  2018-07-12       Impact factor: 5.923

5.  Barth Syndrome: Exploring Cardiac Metabolism with Induced Pluripotent Stem Cell-Derived Cardiomyocytes.

Authors:  Erica M Fatica; Gina A DeLeonibus; Alisha House; Jillian V Kodger; Ryan W Pearce; Rohan R Shah; Liraz Levi; Yana Sandlers
Journal:  Metabolites       Date:  2019-12-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.